Abstract
Background:
Pierson syndrome, caused by mutations in the LAMB2 gene, was originally described as a combination of microcoria and congenital nephrotic syndrome, rapidly progressing to end-stage renal failure.
Case-diagnosis/treatment:
We report a minor variant of Pierson syndrome in a teenage girl with severe myopia since early infancy and proteinuria first detected at age 6. At the age of 11 she was found to carry a unique homozygous non-truncating LAMB2 mutation in exon 2: c.T240G (p.S80R). Renal biopsy revealed mild diffuse mesangial sclerosis and residual expression of laminin β2. Today at age 14, on treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, she continues to have nephrotic range proteinuria, but a normal glomerular filtration rate.
Conclusions:
LAMB2 mutations should be considered in all patients with glomerular proteinuria and abnormal ocular phenotype, irrespective of age and disease severity.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Abnormalities, Multiple / metabolism*
-
Abnormalities, Multiple / physiopathology*
-
Adolescent
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Biopsy
-
Eye Abnormalities / metabolism*
-
Eye Abnormalities / physiopathology*
-
Female
-
Glomerular Filtration Rate / physiology*
-
Humans
-
Kidney / pathology
-
Laminin / genetics
-
Losartan / therapeutic use
-
Mutation / genetics
-
Mutation / physiology
-
Mutation, Missense / genetics
-
Mutation, Missense / physiology
-
Myasthenic Syndromes, Congenital
-
Myopia / etiology
-
Nephrotic Syndrome / pathology
-
Phenotype
-
Proteinuria / etiology*
-
Proteinuria / physiopathology*
-
Pupil Disorders / metabolism*
-
Pupil Disorders / physiopathology*
-
Ramipril / therapeutic use
-
Retinal Detachment / etiology
-
Vision Disorders / etiology
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Laminin
-
laminin beta2
-
Losartan
-
Ramipril